Eledon Pharmaceuticals, Inc.
ELDN
Revenue
0.00
0.000.00%
12 Months ChangeAssets
120.48M
▲39.67M▲49.08%
3 Months ChangeLiabilities
128.98M
▲33.44M▲35.00%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0000950170-24-118497
2024-10-29
Form 8-K
ID: 0000950170-24-117946
2024-10-01
Form 8-K
ID: 0000950170-24-110857
2024-09-20
Form 8-K
ID: 0000950170-24-108465
2024-08-19
Form 10-Q
ID: 0000950170-24-098590
2024-08-14
Form 8-K
ID: 0000950170-24-097206
2024-07-12
Form 8-K
ID: 0000950170-24-083220
2024-07-10
Form 8-K
ID: 0000950170-24-082739
2024-07-10
Form 8-K
ID: 0000950170-24-082730
2024-05-15
Form 10-Q
ID: 0000950170-24-060025